Spencer Health CEO Tom Rhoads lays a road-map for integrating telehealth in clinical research and value-based care.
COVID-19 is accelerating much-needed healthcare and clinical research transformation to focus on the patients first. This global pandemic is pressing the gas pedal hard as people are challenged to receive their medications and stay connected with their healthcare providers and clinical trial teams.
In an article written for MedCity News, Spencer CEO Tom Rhoads identifies this as a clear opportunity to reshape healthcare delivery to integrate telehealth and virtual visits as core care options for high-risk patients and clinical trial participants. “We can expand access and remove traditional barriers so that the focus on people. This will be increasingly critical for the full integration of research and care delivery.”